
CHG-impregnated dressings cut pediatric CLABSI from 18.4% to 2.4% in randomized PICU trial
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A randomized controlled trial of 248 critically ill pediatric patients in an intensive care unit found that chlorhexidine gluconate (CHG)-impregnated dressings reduced central line-associated bloodstream infections from 18.4% down to 2.4%, alongside an 85% reduction in adjusted infection odds.
What NurseJet pulled from the source
In a randomized trial of 248 PICU patients with central venous catheters, CHG-impregnated dressings significantly reduced CLABSI incidence compared with standard transparent dressings (2.4% vs 18.4%; p < 0.001; adjusted OR 0.15; 95% CI 0.04-0.58). Longer catheter dwell time (OR 1.13 per day) and incomplete vaccination (OR 8.68) increased infection risk, while mild skin alterations were modestly higher in the CHG group (16.8% vs 11.2%), primarily among younger infants.
Why this matters for nurses
CLABSI in pediatric intensive care carries severe morbidity, extended hospitalization, and increased mortality. Bedside pediatric nurses manage catheter maintenance and dressing integrity daily. Demonstrating an 85% drop in infection odds reinforces CHG dressings as a potent preventive measure, while underscoring the necessity of close skin checks in delicate neonates and infants.
Bedside takeaway
CHG-impregnated dressings reduced pediatric PICU CLABSI from 18.4% to 2.4%, though nurses must monitor closely for mild skin reactions in young infants.
Key takeaways
- CHG-impregnated central line dressings lowered CLABSI rates from 18.4% to 2.4% in critically ill children (adjusted OR 0.15; 95% CI 0.04-0.58).
- Each additional day of catheter dwell time independently increased CLABSI risk by 13% (OR 1.13; 95% CI 1.04-1.22).
- Absence of complete routine vaccination strongly predicted increased infection risk (OR 8.68; 95% CI 2.48-30.47).
- Localized skin reactions were slightly more frequent with CHG dressings (16.8% vs 11.2%), predominantly observed in young infants.
Practice implications
- Apply CHG-impregnated dressings for eligible pediatric central venous lines in accordance with institutional guidelines and age recommendations. Inspect the insertion site and surrounding cutaneous tissue during every shift for erythema or skin irritation, and prompt medical teams daily regarding catheter necessity to minimize dwell duration.
Limitations & cautions
- Single-center randomized trial conducted in a tertiary pediatric intensive care unit. The open-label nature of dressing appearances prevented blinding of clinical staff, and infants exhibited higher baseline susceptibility to cutaneous irritation.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Intensive & Critical Care Nursing (PubMed)
Intensive & Critical Care Nursing (PubMed). Effectiveness of chlorhexidine gluconate-impregnated dressings in preventing central line-associated bloodstream infection in a paediatric intensive care unit: A randomised controlled trial.
https://pubmed.ncbi.nlm.nih.gov/42102647/
Professional education only


